Here, we reported a whole kinase-protein-protein interaction network, which identified a top ranked AKT kinase-mediated pathway and the related clinical anti-cancer drugs for possibly treating COVID-19 patients by targeting AKT. The gene discussed is AKT1; the disease is COVID-19.